Association of novel mutations and heplotypes
in the preS region of hepatitis B virus with hepatocellular carcinoma

doi:10.1007/s11684-010-0160-0

Front. Med.

2010, Vol. 4

Issue (4) : 419-429 https://doi.org/10.1007/s11684-010-0160-0

Research articles

Association of novel mutations and heplotypes in the preS region of hepatitis B virus with hepatocellular carcinoma

Jia-Xin XIE¹,Jian-Hua YIN¹,Qi ZHANG¹,Rui PU¹,Wen-Ying LU¹,Hong-Wei ZHANG¹,Guang-Wen CAO¹,Jun ZHAO²,Hong-Yang WANG³,

1.Department of Epidemiology, Second Military Medical University, Shanghai 200433, China; 2.Department of Hepatobiliary Surgery, the 3rd Affiliated Hospital, Second Military Medical University, Shanghai 200433, China; 3.International Laboratory for Signal Transduction, the 3rd Affiliated Hospital, Second Military Medical University, Shanghai 200433, China;

Download: PDF(139 KB)
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Abstract The association of viral mutations and haplotypic carriages with mutations in the preS region of hepatitis B virus (HBV) genotypes B and C with hepatocellular carcinoma (HCC) is of great significance for the prediction of this malignancy, but it remains obscure. We analyzed the preS sequences of HBV genotypes B and C from 1172 HBV-infected subjects including 231 patients with HCC. As compared with the HBV-infected subjects without HCC, C2875T, G2946C, A3054C, C3060A, T3066C, C3116T, A3120C, G3191A, A1C, C7A, C10A, A31C, C76T, G105C, and G147C in both genotypes were significantly associated with increased risks of HCC. C2875A, G2950A, G2951A, A3054T, C3060T, T3066A, T3069G, A3120T, and G3191C were significantly associated with increased risks of HCC in genotype C, whereas these mutations were inversely associated with HCC in genotype B. Multivariate regression analyses showed that C76A/T was a novel factor independently associated with an increased risk of HCC, as compared with those without HCC. The frequencies of haplotypes 2964A-3116T-preS2 start codon wild-type-7C, 2964C-3116T-7A-76C, and 2964A-3116T-7C-76A/T were significantly higher in the patients with HCC (P<0.001), whereas a haplotypic carriage with a single mutation and another three wild-types were inversely associated with HCC. Conclusively, the association of HBV mutations in the preS region with HCC depends on HBV genotype and haplotypic carriage with two or more mutations that are each associated with an increased risk of HCC independently.

Keywords hepatitis B virus hepatocellular carcinoma mutation genotype haplotype

Issue Date: 05 December 2010

Cite this article:

Wen-Ying LU,Jia-Xin XIE,Qi ZHANG, et al. Association of novel mutations and heplotypes in the preS region of hepatitis B virus with hepatocellular carcinoma[J]. Front. Med., 2010, 4(4): 419-429.

URL:

https://academic.hep.com.cn/fmd/EN/10.1007/s11684-010-0160-0
https://academic.hep.com.cn/fmd/EN/Y2010/V4/I4/419

	Nguyen V T, Law M G, Dore G J. Hepatitis B-related hepatocellular carcinoma:epidemiological characteristics and disease burden. J Viral Hepat, 2009, 16(7): 453–463 PMID: 19302335
	El-Serag H B, Rudolph K L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 2007, 132(7): 2557–2576 PMID: 17570226
	Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, Zhang P, Xu L, Tan X, Chen J, Cheng S, Schaefer S, Cao G. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellularcarcinoma: compared with chronic hepatitis B and asymptomatic carrierstate in the same area. Carcinogenesis, 2008, 29(9): 1685–1691 PMID: 18192693
	Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G. Associations between hepatitis B virusmutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst, 2009, 101(15): 1066–1082 PMID: 19574418
	Cao G W. Clinical relevance and public health significance ofhepatitis B virus genomic variations. World J Gastroenterol, 2009, 15(46): 5761–5769 PMID: 19998495
	Yin J, Zhang H, He Y, Xie J, Liu S, Chang W, Tan X, Gu C, Lu W, Wang H, Bi S, Cui F, Liang X, Schaefer S, Cao G. Distribution and hepatocellularcarcinoma-related viral properties of hepatitis B virus genotypesin Mainland China: a community-based study. Cancer Epidemiol Biomarkers Prev, 2010, 19(3): 777–786 PMID: 20160279
	Kay A, Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Res, 2007, 127(2): 164–176 PMID: 17383765
	Chen B F, Liu C J, Jow G M, Chen P J, Kao J H, Chen D S. High prevalence and mapping of pre-S deletion in hepatitisB virus carriers with progressive liver diseases. Gastroenterology, 2006, 130(4): 1153–1168 PMID: 16618410
	Gao Z Y, Li T, Wang J, Du J M, Li Y J, Li J, Lu F M, Zhuang H. Mutations in preS genes of genotype Chepatitis B virus in patients with chronic hepatitis B and hepatocellularcarcinoma. J Gastroenterol, 2007, 42(9): 761–768 PMID: 17876546
	Cao Z, Bai X, Guo X, Jin Y, Qian G, Tu H. High prevalence of hepatitis B virus pre-S mutation andits association with hepatocellular carcinoma in Qidong, China. Arch Virol, 2008, 153(10): 1807–1812 PMID: 18726170
	Fang Z L, Sabin C A, Dong B Q, Wei S C, Chen Q Y, Fang K X, Yang J Y, Huang J, Wang X Y, Harrison T J. Hepatitis B virus pre-S deletionmutations are a risk factor for hepatocellular carcinoma: a matchednested case-control study. J Gen Virol, 2008, 89(Pt 11): 2882–2890 PMID: 18931087
	Yin J, Xie J, Zhang H, Shen Q, Han L, Lu W, Han Y, Li C, Ni W, Wang H, Cao G. Significant association of different preS mutations with hepatitis B-related cirrhosisor hepatocellular carcinoma. J Gastroenterol, 2010, 45(10): 1063–1071 PMID: 20419326
	Chen J, Yin J, Tan X, Zhang H, Zhang H, Chen B, Chang W, Schaefer S, Cao G. Improved multiplex-PCR to identify hepatitis B virus genotypes A-F and subgenotypesB1, B2, C1 and C2. J Clin Virol, 2007, 38(3): 238–243 PMID: 17224304
	Zhang H W, Yin J H, Li Y T, Li C Z, Ren H, Gu C Y, Wu H Y, Liang X S, Zhang P, Zhao J F, Tan X J, Lu W, Schaefer S, Cao G W. Risk factors for acute hepatitis B and its progression to chronichepatitis in Shanghai, China. Gut, 2008, 57(12): 1713–1720 PMID: 18755887
	Shen T, Yan X M, Zou Y L, Gao J M, Dong H. Virologic characteristics of hepatitis B virus in patients infected via maternal-fetal transmission. World J Gastroenterol, 2008, 14(37): 5674–5682 PMID: 18837083
	Bock C T, Tillmann H L, Maschek H J, Manns M P, Trautwein C. A preS mutation isolated from a patient with chronic hepatitis B infectionleads to virus retention and misassembly. Gastroenterology, 1997, 113(6): 1976–1982 PMID: 9394738
	Hsieh Y H, Su I J, Wang H C, Chang W W, Lei H Y, Lai M D, Chang W T, Huang W. Pre-S mutant surface antigens in chronichepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis, 2004, 25(10): 2023–2032 PMID: 15180947
	Kekulé A S, Lauer U, Meyer M, Caselmann W H, Hofschneider P H, Koshy R. The preS2/S region of integratedhepatitis B virus DNA encodes a transcriptional transactivator. Nature, 1990, 343(6257): 457–461 PMID: 2153938
	G?bel F, Taschner S, Jurkin J, Konradi S, Vaculik C, Richter S, Kneidinger D, Mühlbacher C, Bieglmayer C, Elbe-Bürger A, Strobl H. Reciprocal role of GATA-1 and vitamin D receptor in human myeloid dendritic celldifferentiation. Blood, 2009, 114(18): 3813–3821 PMID: 19721012
	Andrieux L O, Fautrel A, Bessard A, Guillouzo A, Baffet G, Langou?t S. GATA-1 is essential in EGF-mediatedinduction of nucleotide excision repair activity and ERCC1 expressionthrough ERK2 in human hepatoma cells. Cancer Res, 2007, 67(5): 2114–2123 PMID: 17332341
	Banerjee R, Caruccio L, Zhang Y J, McKercher S, Santella R M. Effects of carcinogen-induced transcription factors on the activationof hepatitis B virus expression in human hepatoblastoma HepG2 cellsand its implication on hepatocellular carcinomas. Hepatology, 2000, 32(2): 367–374 PMID: 10915744

[1]	Amy Lee, Fa-Chyi Lee. Medical oncology management of advanced hepatocellular carcinoma 2019: a reality check[J]. Front. Med., 2020, 14(3): 273-283.
[2]	Shengfen Wang, Yang Zhou, Bing Zhao, Xichao Ou, Hui Xia, Yang Zheng, Yuanyuan Song, Qian Cheng, Xinyang Wang, Yanlin Zhao. Characteristics of compensatory mutations in the rpoC gene and their association with compensated transmission of Mycobacterium tuberculosis[J]. Front. Med., 2020, 14(1): 51-59.
[3]	Wenzhan Jing, Jue Liu, Min Liu. Eliminating mother-to-child transmission of HBV: progress and challenges in China[J]. Front. Med., 2020, 14(1): 21-29.
[4]	Honglu Zhou, Songmei Wang, Lorenz von Seidlein, Xuanyi Wang. The epidemiology of norovirus gastroenteritis in China: disease burden and distribution of genotypes[J]. Front. Med., 2020, 14(1): 1-7.
[5]	Xiaoxin Wu, Lanlan Xiao, Lanjuan Li. Research progress on human infection with avian influenza H7N9[J]. Front. Med., 2020, 14(1): 8-20.
[6]	Yang Zhang, Fang Wang, Xue Chen, Wenjing Liu, Jiancheng Fang, Mingyu Wang, Wen Teng, Panxiang Cao, Hongxing Liu. *Mutation profiling of 16 candidate genes in de novo* acute myeloid leukemia patients**[J]. Front. Med., 2019, 13(2): 229-237.
[7]	Qiongna Dong, Bizhi Shi, Min Zhou, Huiping Gao, Xiaoying Luo, Zonghai Li, Hua Jiang. Growth suppression of colorectal cancer expressing S492R EGFR by monoclonal antibody CH12[J]. Front. Med., 2019, 13(1): 83-93.
[8]	Min Zhang, Jingwen Yang, Wenjing Hua, Zhong Li, Zenghui Xu, Qijun Qian. Monitoring checkpoint inhibitors: predictive biomarkers in immunotherapy[J]. Front. Med., 2019, 13(1): 32-44.
[9]	Renyu Zhang, Zhao Zhang, Zekun Liu, Ding Wei, Xiaodong Wu, Huijie Bian, Zhinan Chen. Adoptive cell transfer therapy for hepatocellular carcinoma[J]. Front. Med., 2019, 13(1): 3-11.
[10]	Liru Qiu, Fengjie Yang, Yonghua He, Huiqing Yuan, Jianhua Zhou. Clinical characterization and diagnosis of cystic fibrosis through exome sequencing in Chinese infants with Bartter-syndrome-like hypokalemia alkalosis[J]. Front. Med., 2018, 12(5): 550-558.
[11]	Shasha Zhu, Huimin Zhang, Li Bai. NKT cells in liver diseases[J]. Front. Med., 2018, 12(3): 249-261.
[12]	Dong Wang, Min Tian, Guanglin Cui, Dao Wen Wang. Antithrombin deficiency and decreased protein C activity in a young man with venous thromboembolism: a case report[J]. Front. Med., 2018, 12(3): 319-323.
[13]	Guangbiao Zhou, Xinchun Zhao. Carcinogens that induce the A:T>T:A nucleotide substitutions in the genome[J]. Front. Med., 2018, 12(2): 236-238.
[14]	Haican Liu, Yuanyuan Zhang, Zhiguang Liu, Jinghua Liu, Yolande Hauck, Jiao Liu, Haiyan Dong, Jie Liu, Xiuqin Zhao, Bing Lu, Yi Jiang, Gilles Vergnaud, Christine Pourcel, Kanglin Wan. *Associations between Mycobacterium tuberculosis* Beijing genotype and drug resistance to four first-line drugs: a survey in China**[J]. Front. Med., 2018, 12(1): 92-97.
[15]	Min Yu, Zonghai Li. Natural killer cells in hepatocellular carcinoma: current status and perspectives for future immunotherapeutic approaches[J]. Front. Med., 2017, 11(4): 509-521.

Viewed

Full text

Abstract

Cited

Shared

Discussed